ISBN: 9781588298584

This book provides the reader with broad perspectives and breadth of knowledge on current topics related to the use of proteomic strategies in cancer therapy as well as anticipated challe… Altro …

This book provides the reader with broad perspectives and breadth of knowledge on current topics related to the use of proteomic strategies in cancer therapy as well as anticipated challenges that may arise from its application in daily practice. The book is divided into 4 parts. The first part begins with the current technologies used in proteomics that allow for protein profiling and for the identification of druggable targets in human samples. Mass spectrometry based protein characterization and protein microarrays hold great promise of predicting response to specific drugs in cancer therapy. The second part deals with the use proteomics in cell signaling. At the present, the pharmaceutical and biotechnology industries have many potentially useful small molecule inhibitors of many pathways important in cancer that have yet to be taken to clinical trials. Understanding protein-protein interaction and posttranslational modifications through proteomics will likely make it much more feasible to do effective clinical trials of these small molecules alone and in combinations to overcome drug resistance and improve patient care. The third part of the book moves from signaling to actual clinical applications of proteomics in cancer therapy. Case studies in may tumor types are provided to show the feasibility of generating the critical information needed to individualization of therapy in cancer patients. The final part of the book provides in depth information on annotating the human proteome and the role of Food and Drug Administration (FDA) in regulating the use of proteomics in cancer therapy. To functionally annotate the human proteome, the Swiss Institute for Bioinformatics (SIB) and the European Bioinformatics Institute (EBI) initiated a major effort to distribute to the scientific community highly integrated information on human protein sequences. This initiative, which is called the Human Proteomics Initiative (HPI) aims to provide for each known human protein a wealth of information that include the description of its function, domain and protein family classification, subcellular location, posttranslational modifications, variants and similarities to other proteins. Integration of bioinformatics into clinical application of proteomics in cancer therapy is outlined as well as regulations and policy of commercial application of proteomics in patient care. Books > Biomedicine Hard cover, Springer Shop<

ISBN: 9781588298584

Over the past 20 years or so, there have been tremendous advances in our understanding of how normal cells transform to cancer and the importance of signaling pathways in cancer initiatio… Altro …

Over the past 20 years or so, there have been tremendous advances in our understanding of how normal cells transform to cancer and the importance of signaling pathways in cancer initiation and progression. Therefore, proteomics technologies must be improved for more global analysis of protein content of cells, tissues and body fluids as well as the posttranslational modifications to allow for proper detections and validation. In Cancer Proteomics, the authors collectively provide the current status of proteomics in cancer therapy and offers the existing technologies used in proteomics that allow for protein profiling and for the identification of druggable targets in human samples. Mass spectrometry based protein characterization and protein microarrays hold great promise of predicting response to specific drugs in cancer therapy. Insightful to the reader with broad perspectives on topics related to the use of proteomic strategies in cancer therapy, Cancer Proteomics offers anticipated challenges that may arise from its application in daily practice. This book covers current topics related to the use of proteomic strategies in cancer therapy as well as anticipated challenges that may arise from its application in daily practice. It details current technologies used in proteomics, examines the use proteomics in cell signaling, presents clinical applications of proteomics in cancer therapy, and looks at the role of the FDA in regulating the use of proteomics. Bücher, Hörbücher & Kalender / Bücher / Sachbuch / Medizin / Fachbücher / Nichtklinische Medizin<

2008, ISBN: 9781588298584

Erscheinungsdatum: 01/2008, Medium: Buch, Einband: Gebunden, Titel: Cancer Proteomics, Titelzusatz: From Bench to Bedside, Redaktion: Daoud, Sayed S., Verlag: Springer-Verlag GmbH // Huma… Altro …

Erscheinungsdatum: 01/2008, Medium: Buch, Einband: Gebunden, Titel: Cancer Proteomics, Titelzusatz: From Bench to Bedside, Redaktion: Daoud, Sayed S., Verlag: Springer-Verlag GmbH // Humana Press, Sprache: Englisch, Schlagworte: Bioinformatik // Informatik // Krebs // Krankheit // Onkologie // Radioonkologie // Proteom // Forschung // medizinisch // psychologisch // Heilkunde // Humanmedizin // Medizin // Biochemie // Chemie // MEDICAL // Oncology // SCIENCE // Life Sciences // Biochemistry // für die Hochschulausbildung // Medizinische Informatik // DV-gestützte Biologie // Vorklinische Medizin // Grundlagenwissenschaften, Rubrik: Allgemeinmedizin // Diagnostik, Therapie, Seiten: 264, Abbildungen: 5 farb. Abb., 16 schw.-w. Zeichn., 6 schw.-w. Tabellen, Reihe: Cancer Drug Discovery and Development, Gewicht: 588 gr, Verkäufer: averdo Sachbücher<

2008, ISBN: 9781588298584

[ED: Gebunden], [PU: Humana Press], This book covers current topics related to the use of proteomic strategies in cancer therapy as well as anticipated challenges that may arise from its … Altro …

[ED: Gebunden], [PU: Humana Press], This book covers current topics related to the use of proteomic strategies in cancer therapy as well as anticipated challenges that may arise from its application in daily practice. It details current technologies used in proteomics, examines the use proteomics in cell signaling, presents clinical applications of proteomics in cancer therapy, and looks at the role of the FDA in regulating the use of proteomics., DE, [SC: 0.00], Neuware, gewerbliches Angebot, 264, [GW: 641g], Sofortüberweisung, PayPal, Banküberweisung<

2008, ISBN: 1588298582

Gebundene Ausgabe Bioinformatik, Informatik / Bioinformatik, Krebs (Krankheit) / Onkologie, Onkologie - Radioonkologie, Proteom, Forschung (medizinisch, psychologisch), Heilkunde, Humanm… Altro …

Gebundene Ausgabe Bioinformatik, Informatik / Bioinformatik, Krebs (Krankheit) / Onkologie, Onkologie - Radioonkologie, Proteom, Forschung (medizinisch, psychologisch), Heilkunde, Humanmedizin, Medizin, Biochemie, Chemie / Biochemie, MEDICAL / Oncology, SCIENCE / Life Sciences / Biochemistry, für die Hochschulausbildung, Medizinische Informatik, DV-gestützte Biologie/Bioinformatik, Onkologie, Vorklinische Medizin, Grundlagenwissenschaften, mit Schutzumschlag neu, [PU:Springer-Verlag GmbH; Humana Press]<